285 related articles for article (PubMed ID: 25864384)
1. CDK1 structures reveal conserved and unique features of the essential cell cycle CDK.
Brown NR; Korolchuk S; Martin MP; Stanley WA; Moukhametzianov R; Noble MEM; Endicott JA
Nat Commun; 2015 Apr; 6():6769. PubMed ID: 25864384
[TBL] [Abstract][Full Text] [Related]
2. SU9516: biochemical analysis of cdk inhibition and crystal structure in complex with cdk2.
Moshinsky DJ; Bellamacina CR; Boisvert DC; Huang P; Hui T; Jancarik J; Kim SH; Rice AG
Biochem Biophys Res Commun; 2003 Oct; 310(3):1026-31. PubMed ID: 14550307
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells.
Martinsson-Ahlzén HS; Liberal V; Grünenfelder B; Chaves SR; Spruck CH; Reed SI
Mol Cell Biol; 2008 Sep; 28(18):5698-709. PubMed ID: 18625720
[TBL] [Abstract][Full Text] [Related]
4. Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.
Salamina M; Montefiore BC; Liu M; Wood DJ; Heath R; Ault JR; Wang LZ; Korolchuk S; Baslé A; Pastok MW; Reeks J; Tatum NJ; Sobott F; Arold ST; Pagano M; Noble MEM; Endicott JA
J Mol Biol; 2021 Mar; 433(5):166795. PubMed ID: 33422522
[TBL] [Abstract][Full Text] [Related]
5. Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors.
Nandha Premnath P; Craig S; McInnes C
J Vis Exp; 2015 Oct; (105):e52441. PubMed ID: 26554946
[TBL] [Abstract][Full Text] [Related]
6. A novel member of the cyclin-dependent kinase family in Paramecium tetraurelia.
Zhang H; Berger JD
J Eukaryot Microbiol; 1999; 46(5):482-91. PubMed ID: 10519216
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of human cyclin B.
Petri ET; Errico A; Escobedo L; Hunt T; Basavappa R
Cell Cycle; 2007 Jun; 6(11):1342-9. PubMed ID: 17495533
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.
De Azevedo WF; Leclerc S; Meijer L; Havlicek L; Strnad M; Kim SH
Eur J Biochem; 1997 Jan; 243(1-2):518-26. PubMed ID: 9030780
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
Schulze-Gahmen U; Jung JU; Kim SH
Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
[TBL] [Abstract][Full Text] [Related]
10. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects.
Mettey Y; Gompel M; Thomas V; Garnier M; Leost M; Ceballos-Picot I; Noble M; Endicott J; Vierfond JM; Meijer L
J Med Chem; 2003 Jan; 46(2):222-36. PubMed ID: 12519061
[TBL] [Abstract][Full Text] [Related]
11. New structural insights into phosphorylation-free mechanism for full cyclin-dependent kinase (CDK)-cyclin activity and substrate recognition.
Zheng F; Quiocho FA
J Biol Chem; 2013 Oct; 288(42):30682-30692. PubMed ID: 24022486
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
[TBL] [Abstract][Full Text] [Related]
13. Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation.
Gondeau C; Gerbal-Chaloin S; Bello P; Aldrian-Herrada G; Morris MC; Divita G
J Biol Chem; 2005 Apr; 280(14):13793-800. PubMed ID: 15649889
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a gamma-herpesvirus cyclin-cdk complex.
Card GL; Knowles P; Laman H; Jones N; McDonald NQ
EMBO J; 2000 Jun; 19(12):2877-88. PubMed ID: 10856233
[TBL] [Abstract][Full Text] [Related]
15. Molecular models of cyclin-dependent kinase 1 complexed with inhibitors.
Canduri F; Uchoa HB; de Azevedo WF
Biochem Biophys Res Commun; 2004 Nov; 324(2):661-6. PubMed ID: 15474478
[TBL] [Abstract][Full Text] [Related]
16. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.
Brown NR; Noble ME; Endicott JA; Johnson LN
Nat Cell Biol; 1999 Nov; 1(7):438-43. PubMed ID: 10559988
[TBL] [Abstract][Full Text] [Related]
17. Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition.
Wood DJ; Korolchuk S; Tatum NJ; Wang LZ; Endicott JA; Noble MEM; Martin MP
Cell Chem Biol; 2019 Jan; 26(1):121-130.e5. PubMed ID: 30472117
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of human Wee1B, a new member of the Wee1 family of Cdk-inhibitory kinases.
Nakanishi M; Ando H; Watanabe N; Kitamura K; Ito K; Okayama H; Miyamoto T; Agui T; Sasaki M
Genes Cells; 2000 Oct; 5(10):839-47. PubMed ID: 11029659
[TBL] [Abstract][Full Text] [Related]
19. Binding of HTm4 to cyclin-dependent kinase (Cdk)-associated phosphatase (KAP).Cdk2.cyclin A complex enhances the phosphatase activity of KAP, dissociates cyclin A, and facilitates KAP dephosphorylation of Cdk2.
Chinami M; Yano Y; Yang X; Salahuddin S; Moriyama K; Shiroishi M; Turner H; Shirakawa T; Adra CN
J Biol Chem; 2005 Apr; 280(17):17235-42. PubMed ID: 15671017
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
